1Fichtenbaum CI;Powderly WG.Refractory mucosal candidiasis in patients with human immunodeficiency virus infection[J],1998(03).
2Rex J H;Rinaidi MG;Nailer MA.Resistance of candida species to fluconazole,1995(01).
3Clancy C J;Nguyen MH.Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B:results from a multicenter prospective study of candidemia[J],1999(05).
4Sheehan DJ;Hitchcock CA;Sibley CM.Current and emerging azole antifungal agents[J],1999(01).
5Andes D;Stamsted T;Conklin R.Pharmacodynamics of amphotericin B in a neutropenicmouse disseminated-candidiasis model[J],2001(03).
6Seo K;Akiyoshi H;Ohnishi Y.Alteration of cell wall composition leads to amphotericin B resistance in Aspergillus flavus[J],1999(11).
7Hoban DI;Zhanel GG;Karlowsky JA.In vitro susceptibilities of Candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients[J],1999(06).
8Perfect JR;Cox GM.Drug resistance in Cryptococcus neoformans,1999(04).
9Schorling SR;Kortinga HC;Froschb M.The role of Candida dubliniensis in oral candidiasis in human immunodeficiency virus-infected individuals[J],2000(01).
10Barchiesi F;Di Francesco LF;Compagnucci P.Genotypic identification of sequential Candida albicans isolates from AIDS patients by polymerase chain reaction techniques[J],1997(08).
6Vandenbossche I,Vaneechoutle M,Vandevenne M et al.Susceptibiution testing of fluconazole by the NCCLS broth macrodilution method,E-test ,and disk diffusion for application in the routine laboratory. J Clin Micobiol,2002;40(3):918~21.
7Jahn B,Martin E,Stueben A et al. Susceptibility Testing of Candida albicans and Aspergillus specie by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazoly)-2,5-diphenyl-2H-tetrazolium bromide assay. J Clin Microbiol,1995;33(3):661~7.
8Rex JH, Rinaldi MG, Pfaller MA. Resistance of candida species to fluconazale. Antimicrob Agents Chemother, 1995;39(1):1~8.
9Te Dorsthorst DT, Verweij PE, Meletiadis J et al. In vitro interaction of flucytosine combined with amphotericin B of fluconazale against. thirty-five yeast isolates determined by both the fractional inhibitory concentration zndex and the response surfact approach. Antimicrob Agents Chemother, 2002;46(9):2982~9.
8Vandenbossche I,Vaneechoutle M,Vandevenne M et al.Susceptibiution testing of fluconazole by the NCCLS broth macrodilution method,E-test ,and disk diffusion for application in the routine laboratory. J Clin Micobiol,2002;40(3):918~21.
9Jahn B,Martin E,Stueben A et al. Susceptibility Testing of Candida albicans and Aspergillus specie by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazoly)-2,5-diphenyl-2H-tetrazolium bromide assay. J Clin Microbiol,1995;33(3):661~7.
10Rex JH, Rinaldi MG, Pfaller MA. Resistance of candida species to fluconazale. Antimicrob Agents Chemother, 1995;39(1):1~8.